These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28199006)

  • 21. An exploratory analysis of fear of recurrence among African-American breast cancer survivors.
    Taylor TR; Huntley ED; Sween J; Makambi K; Mellman TA; Williams CD; Carter-Nolan P; Frederick W
    Int J Behav Med; 2012 Sep; 19(3):280-7. PubMed ID: 21915625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Distress Reduction on Behavioral Correlates and A1C in African American Women with Uncontrolled Type 2 Diabetes: Results from EMPOWER.
    Cummings DM; Lutes LD; Littlewood K; Solar C; Hambidge B; Gatlin P
    Ethn Dis; 2017; 27(2):155-160. PubMed ID: 28439186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.
    Agnew S; Crawford M; MacPherson I; Shiramizu V; Fleming L
    Breast; 2024 Jun; 75():103731. PubMed ID: 38599048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer.
    Knobf MT
    J Clin Oncol; 1986 May; 4(5):678-84. PubMed ID: 3754573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. African American women share 'real talk' stories about fatigue related to breast cancer treatment.
    Morgan PD; Tyler I; Fogel J; Barnett K
    ABNF J; 2014; 25(4):116-22. PubMed ID: 25612398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in women treated with chemotherapy for breast cancer in Cali, Colombia.
    Mejía-Rojas ME; Contreras-Rengifo A; Hernández-Carrillo M
    Biomedica; 2020 Jun; 40(2):349-361. PubMed ID: 32673462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom Clusters Change Over Time in Women Receiving Adjuvant Chemotherapy for Breast Cancer.
    Albusoul RM; Berger AM; Gay CL; Janson SL; Lee KA
    J Pain Symptom Manage; 2017 May; 53(5):880-886. PubMed ID: 28062343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
    Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
    Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity.
    McCall MK; Connolly M; Nugent B; Conley YP; Bender CM; Rosenzweig MQ
    J Cancer Educ; 2020 Jun; 35(3):428-440. PubMed ID: 31392599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.
    Tross S; Herndon J; Korzun A; Kornblith AB; Cella DF; Holland JF; Raich P; Johnson A; Kiang DT; Perloff M; Norton L; Wood W; Holland JC
    J Natl Cancer Inst; 1996 May; 88(10):661-7. PubMed ID: 8627642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnicity and persistent symptom burden in breast cancer survivors.
    Fu OS; Crew KD; Jacobson JS; Greenlee H; Yu G; Campbell J; Ortiz Y; Hershman DL
    J Cancer Surviv; 2009 Dec; 3(4):241-50. PubMed ID: 19859813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy.
    Fang P; Tan KS; Troxel AB; Rengan R; Freedman G; Lin LL
    Breast Cancer Res Treat; 2013 Aug; 141(1):125-33. PubMed ID: 23942874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.
    Liu L; Fiorentino L; Natarajan L; Parker BA; Mills PJ; Sadler GR; Dimsdale JE; Rissling M; He F; Ancoli-Israel S
    Psychooncology; 2009 Feb; 18(2):187-94. PubMed ID: 18677716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.
    Hershman D; Weinberg M; Rosner Z; Alexis K; Tiersten A; Grann VR; Troxel A; Neugut AI
    J Natl Cancer Inst; 2003 Oct; 95(20):1545-8. PubMed ID: 14559877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Symptoms on Quality of Life during Chemotherapy in African-American Women with Breast Cancer.
    Gaton-Johansson F; Watkins CC; Kanu IK; Whitehouse E; Sarenmalm EK; Brovall M; Kozachik SL
    J Natl Black Nurses Assoc; 2015 Dec; 26(2):7-16. PubMed ID: 27045153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quality of life of African American women with breast cancer.
    Northouse LL; Caffey M; Deichelbohrer L; Schmidt L; Guziatek-Trojniak L; West S; Kershaw T; Mood D
    Res Nurs Health; 1999 Dec; 22(6):449-60. PubMed ID: 10630287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer.
    Paladino AJ; Anderson JN; Krukowski RA; Waters T; Kocak M; Graff C; Blue R; Jones TN; Buzaglo J; Vidal G; Schwartzberg L; Graetz I
    BMC Health Serv Res; 2019 Dec; 19(1):977. PubMed ID: 31856812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic Hardship and Associated Factors of Women With Early-Stage Breast Cancer Prior to Chemotherapy Initiation.
    Abujaradeh H; Mazanec SR; Sereika SM; Connolly MC; Bender CM; Gordon BB; Rosenzweig M
    Clin Breast Cancer; 2024 Jan; 24(1):36-44. PubMed ID: 37852896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer.
    Beesley VL; Webber K; Nagle CM; DeFazio A; Obermair A; Williams M; Friedlander M; Webb PM;
    Gynecol Oncol; 2020 Oct; 159(1):179-186. PubMed ID: 32773150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.